Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

Recruiting

Observational StudyProspective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

Sponsor:

National Cancer Institute (NCI)

Code:

NCT04431024

Conditions

Familial Cancer

BRCA1-Associated Protein-1 (BAP1) Mutations

Tumor Predisposition Syndrome (TPDS)

Mesothelioma

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-17. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2025-07-14.